| TICAGRELOR |
替格瑞洛 |
274693-27-5 |
| gne-131 |
CS-2887 |
1629063-81-5 |
| Pimodivir |
VX-787 |
1629869-44-8 |
| GSK3145095 |
GSK3145095 |
1622849-43-7 |
| JNJ-632 |
JNJ-632 |
1572510-42-9 |
| BLU 9931 |
BLU 9931 |
1538604-68-0 |
| Cyclopenta[c]pyrrole-2(1H)-carboxamide, hexahydro-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, (3aα,5α,6aα)- |
化合物SHR0302 |
1445987-21-2 |
| (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide |
MDK-7933 |
1417997-93-3 |
| Cilofexor |
CILOFEXOR; GS-9674; GS 9674; GS9674; |
1418274-28-8 |
| nAChR agonist1 |
化合物NACHR AGONIST 1 |
1394371-75-5 |
| Benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]- |
AMP-945 |
1393653-34-3 |
| 3-(3-Methoxyphenyl)-2-Methyl-N-(2-(thiazol-4-yl)-1H-benzo[d]iMidazol-5-yl)propanaMide hydrochloride |
RY785 |
1393748-80-5 |
| Acetamide, 2-[3-[6-ethoxy-4-[[4-(1H-pyrazol-4-yl)phenyl]amino]-2-quinazolinyl]phenoxy]-N-(1-methylethyl)- |
KL11743 |
1369452-53-8 |
| 4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
4′-[[2,3-Dimethyl-5-[[[(1S)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1H-indol-1-yl]methyl]- [1,1′-Biphenyl]-2-carboxylic acid |
1338259-05-4 |
| LIK066 |
1291094-73-9 |
1291094-73-9 |
| 3-Cyclopropyl-pyrrolidine |
3-环丙基-吡咯烷 |
1250004-31-9 |
| Danicopan |
Danicopan |
1903768-17-1 |
| incb057643 |
incb057643 |
1820889-23-3 |
| ONO-8590580 |
CS-2894 |
1802661-73-9 |
| BLU-285 |
阿伐普替尼 |
1703793-34-3 |
QQ
